<DOC>
	<DOCNO>NCT00779246</DOCNO>
	<brief_summary>This pilot study medical intensive care unit evaluate clinical cost-effectiveness active surveillance program methicillin-resistant Staphylococcus aureus ( MRSA ) , compare routine daily bath chlorhexidine gluconate ( CHG ) -impregnated cloth . Outcomes include rate MRSA acquisition , hospital-acquired infection ( e.g. , catheter-associated bloodstream infection ) .</brief_summary>
	<brief_title>Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures Prevent Methicillin-resistant Staphylococcus Aureus &amp; Other Hospital Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<criteria>All patient admit medical intensive care unit ( ICU ) eligible inclusion Patient refusal Contraindication nasal swab ( arm 1 ) Allergy/sensitivity chlorhexidine gluconate ( CHG ) ( arm 2 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Methicillin resistance</keyword>
	<keyword>Infection control</keyword>
	<keyword>Staphylococcus aureus</keyword>
	<keyword>Cross infection</keyword>
	<keyword>Epidemiology</keyword>
	<keyword>Chlorhexidine</keyword>
</DOC>